To include your compound in the COVID-19 Resource Center, submit it here.

Novartis names CMO Narasimhan to replace CEO Jimenez

On Monday, Novartis AG (NYSE:NVS; SIX:NOVN) said CMO Vasant Narasimhan will replace CEO Joseph Jimenez, effective Feb. 1, 2018. Jimenez, who is retiring, led the pharma through multiple patent expirations, business integrations and reorganizations.

Jimenez joined Novartis in 2007 as head of the consumer health division, and also served as division head of Novartis Pharmaceuticals until being named to the CEO role in

Read the full 629 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers